Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of MCS-5 in Treating Male Oligoasthenospermia (MCS_MOS)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2011 by Health Ever Bio-Tech Co., Ltd..
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Health Ever Bio-Tech Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01016340
First received: November 17, 2009
Last updated: December 13, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2013
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)